Cipher Pharmaceuticals Inc.

TSX:CPH Voorraadrapport

Marktkapitalisatie: CA$380.3m

Cipher Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Cipher Pharmaceuticals heeft een totaal eigen vermogen van $98.9M en een totale schuld van $40.0M, wat de schuld-eigenvermogensverhouding op 40.5% brengt. De totale activa en totale passiva bedragen respectievelijk $153.9M en $55.0M. De EBIT Cipher Pharmaceuticals is $9.9M waardoor de rentedekking -6.9 is. Het heeft contanten en kortetermijnbeleggingen van $9.5M.

Belangrijke informatie

40.5%

Verhouding schuld/eigen vermogen

US$40.00m

Schuld

Rente dekkingsratio-6.9x
ContantUS$9.52m
AandelenUS$98.86m
Totaal verplichtingenUS$55.00m
Totaal activaUS$153.86m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $29.1M ) CPH } overtreffen de korte termijn passiva ( $14.5M ).

Langlopende schulden: De kortetermijnactiva van CPH ( $29.1M ) dekken de langetermijnschulden ( $40.5M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 30.8% ) CPH wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van CPH is de afgelopen 5 jaar gestegen van 38.6% naar 40.5%.

Schuldendekking: De schuld van CPH wordt goed gedekt door de operationele kasstroom ( 32.7% ).

Rentedekking: CPH verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y